TY - JOUR
T1 - Can smoking duration alone replace pack-years to predict the risk of smoking-related oncogenic mutations in non-small cell lung cancer? A cross-sectional study in Japan
AU - Ogawa, Koichi
AU - Koh, Yasuhiro
AU - Kaneda, Hiroyasu
AU - Izumi, Motohiro
AU - Matsumoto, Yoshiya
AU - Sawa, Kenji
AU - Fukui, Mitsuru
AU - Taniguchi, Yoshihiko
AU - Yoshimoto, Naoki
AU - Tamiya, Akihiro
AU - Ando, Masahiko
AU - Kubo, Akihito
AU - Isa, Shun Ichi
AU - Saka, Hideo
AU - Matsumura, Akihide
AU - Kawaguchi, Tomoya
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2020.
PY - 2020/9/9
Y1 - 2020/9/9
N2 - Objective To investigate whether smoking duration alone can replace pack-years to predict the risk of oncogenic mutations in non-small cell lung cancer (NSCLC). Design A cross-sectional study using the baseline dataset from the Japan Molecular Epidemiology for Lung Cancer Study. Setting Forty-three medical institutions nationwide in Japan. Participants From July 2012 to December 2013, 957 patients with newly diagnosed stage I-IIIB NSCLC who underwent surgery were enrolled, and molecular analyses were performed on 876 samples (from 441 ever-smokers and 435 never-smokers). Main outcomes measured We calculated the area under the receiver operating characteristic curve (AUC) values using logistic regression to compare between the predictive values of smoking duration and pack-years for mutational frequencies in the v-Ki-ras2 Kirsten rat sarcoma (KRAS), tumour suppressor p53 (TP53), and epidermal growth factor receptor (EGFR) genes and for cytosine-to-adenine base substitution (C>A). Results For predicting KRAS mutations, the AUC values for smoking duration and pack-years were 0.746 (95% CI 0.682 to 0.800) and 0.759 (95% CI 0.700 to 0.810), respectively (p=0.058). For predicting KRAS mutations in smokers, the AUC values for smoking duration and pack-years were 0.772 (95% CI 0.697 to 0.833) and 0.787 (95% CI 0.714 to 0.845), respectively (p=0.036). There were no significant differences between the AUC values for smoking duration and pack-years in terms of predicting TP53 and EGFR mutations and C>A. Pack-years was a significantly better predictor of KRAS mutations than smoking duration. Conclusion Smoking duration was not significantly different from pack-years in predicting the likelihood of smoking-related gene mutations. Given the recall bias in obtaining smoking information, smoking duration alone should be considered for further investigation as a simpler alternative to pack-years.
AB - Objective To investigate whether smoking duration alone can replace pack-years to predict the risk of oncogenic mutations in non-small cell lung cancer (NSCLC). Design A cross-sectional study using the baseline dataset from the Japan Molecular Epidemiology for Lung Cancer Study. Setting Forty-three medical institutions nationwide in Japan. Participants From July 2012 to December 2013, 957 patients with newly diagnosed stage I-IIIB NSCLC who underwent surgery were enrolled, and molecular analyses were performed on 876 samples (from 441 ever-smokers and 435 never-smokers). Main outcomes measured We calculated the area under the receiver operating characteristic curve (AUC) values using logistic regression to compare between the predictive values of smoking duration and pack-years for mutational frequencies in the v-Ki-ras2 Kirsten rat sarcoma (KRAS), tumour suppressor p53 (TP53), and epidermal growth factor receptor (EGFR) genes and for cytosine-to-adenine base substitution (C>A). Results For predicting KRAS mutations, the AUC values for smoking duration and pack-years were 0.746 (95% CI 0.682 to 0.800) and 0.759 (95% CI 0.700 to 0.810), respectively (p=0.058). For predicting KRAS mutations in smokers, the AUC values for smoking duration and pack-years were 0.772 (95% CI 0.697 to 0.833) and 0.787 (95% CI 0.714 to 0.845), respectively (p=0.036). There were no significant differences between the AUC values for smoking duration and pack-years in terms of predicting TP53 and EGFR mutations and C>A. Pack-years was a significantly better predictor of KRAS mutations than smoking duration. Conclusion Smoking duration was not significantly different from pack-years in predicting the likelihood of smoking-related gene mutations. Given the recall bias in obtaining smoking information, smoking duration alone should be considered for further investigation as a simpler alternative to pack-years.
KW - epidemiology
KW - molecular aspects
KW - respiratory tract tumours
UR - http://www.scopus.com/inward/record.url?scp=85090821262&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090821262&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2019-035615
DO - 10.1136/bmjopen-2019-035615
M3 - Article
C2 - 32907893
AN - SCOPUS:85090821262
SN - 2044-6055
VL - 10
JO - BMJ Open
JF - BMJ Open
IS - 9
M1 - e035615
ER -